An alternative approach to somatic cell gene therapy - PubMed (original) (raw)

An alternative approach to somatic cell gene therapy

D St Louis et al. Proc Natl Acad Sci U S A. 1988 May.

Abstract

Mouse primary skin fibroblasts were infected with a recombinant retrovirus containing human factor IX cDNA. Bulk infected cells capable of synthesizing and secreting biologically active human factor IX protein were embedded in collagen, and the implant was grafted under the epidermis. Sera from the transplanted mice contain human factor IX protein for at least 10-12 days. Loss of immunoreactive human factor IX protein in the mouse serum is not due to graft rejection. Instead, the mouse serum contains anti-human factor IX antibodies, which react with the protein. We suggest that retroviral-infected primary skin fibroblasts offer an alternative approach to somatic cell gene therapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Biol. 1972 Sep;54(3):626-37 - PubMed
    1. J Cell Biol. 1963 May;17:299-313 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1274-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
    1. CRC Crit Rev Biochem. 1980;8(2):191-223 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources